Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 38 entries
View as:

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Phase: N/A Priority: Normal
NCT ID: NCT01617135 Org: User:
Start: 05/31/12 End: 12/31/12 Due: 12/31/13

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

Phase: N/A Priority: Normal
NCT ID: NCT02316847 Org: User:
Start: 12/31/14 End: 09/30/16 Due: 09/30/17

Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00053417 Org: User:
Start: 02/28/03 End: 12/31/03 Due: 12/31/04

Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01328379 Org: User:
Start: 03/31/11 End: 07/31/12 Due: 07/31/13

Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02609945 Org: User:
Start: 11/30/15 End: 04/30/16 Due: 04/30/17

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01803867 Org: User:
Start: 03/31/13 End: 01/31/15 Due: 01/31/16

Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury

Phase: N/A Priority: Normal
NCT ID: NCT00041717 Org: User:
Start: 07/31/02 End: 05/31/04 Due: 05/31/05

A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01944683 Org: User:
Start: 09/30/13 End: 07/31/16 Due: 07/31/17

Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)

Phase: N/A Priority: Normal
NCT ID: NCT02474407 Org: User:
Start: 06/30/15 End: 07/31/16 Due: 07/31/17

Study of Oral Fampridine-SR in Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00127530 Org: User:
Start: 05/31/05 End: 09/30/06 Due: 09/30/07

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

Phase: N/A Priority: Normal
NCT ID: NCT01468350 Org: User:
Start: 12/31/11 End: 03/31/13 Due: 03/31/14

A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults

Phase: N/A Priority: Normal
NCT ID: NCT02633839 Org: User:
Start: 12/31/15 End: 06/30/16 Due: 06/30/17

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

Phase: N/A Priority: Normal
NCT ID: NCT02398461 Org: User:
Start: 04/30/15 End: 09/21/17 Due: 09/21/18

Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy

Phase: N/A Priority: Normal
NCT ID: NCT01405950 Org: User:
Start: 05/31/11 End: 03/31/12 Due: 03/31/13

A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02812394 Org: User:
Start: 06/30/16 End: 09/30/16 Due: 09/30/17

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00654927 Org: User:
Start: 11/30/03 End: 04/30/11 Due: 04/30/12

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

Phase: N/A Priority: Normal
NCT ID: NCT00648908 Org: User:
Start: 06/30/06 End: 04/30/11 Due: 04/30/12

Randomized Safety Study of CVT-301 Compared to an Observational Control Group

Phase: N/A Priority: Normal
NCT ID: NCT02352363 Org: User:
Start: 03/31/15 End: 05/31/17 Due: 05/31/18

Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Phase: N/A Priority: Normal
NCT ID: NCT02242487 Org: User:
Start: 03/31/15 End: 05/31/18 Due: 05/31/19

A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.

Phase: N/A Priority: Normal
NCT ID: NCT02271217 Org: User:
Start: 12/31/14 End: 10/31/16 Due: 10/31/17

Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00483652 Org: User:
Start: 05/31/07 End: 05/31/08 Due: 05/31/09

A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)

Phase: N/A Priority: Normal
NCT ID: NCT02807675 Org: User:
Start: 06/30/16 End: 11/30/16 Due: 11/30/17

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

Phase: N/A Priority: Normal
NCT ID: NCT00649792 Org: User:
Start: 08/31/07 End: 04/30/11 Due: 04/30/12

A Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02663999 Org: User:
Start: 01/31/16 End: 06/30/16 Due: 06/30/17

A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder

Phase: N/A Priority: Normal
NCT ID: NCT02905227 Org: User:
Start: 09/30/16 End: 12/31/16 Due: 12/31/17